The ReNeuron Group Plc has secured new funding commitments of £33 million, enabling it to advance its three allogeneic stem cell programmes through Phase 2 development. The funding includes a large grant from the Welsh government. ---Subscribe to MedNous to access this article--- Regenerative Medicine Company News Finance, Grants, Deals
